Personalized Medicine: The case for diagnostics focuses on cost and effectiveness

Re-posted from the Cross-Border Biotech Blog

By Jeremy Grushcow

A report in FierceBiotech recently distilled the views of three life science VCs on trends to watch in 2010.

Share

Speak Your Mind

*